Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01904071 · ClinicalTrials.gov registry record · Phase 4

Ultrasound Guided Pain Control Versus Standard Treatment in Emergency Department HIP Fracture Patients

A Phase 4 study, sponsored by Antonios Likourezos.

Completed
Registry status
Phase 4
Development phase
64
Enrollment target

NCT01904071 is a Phase 4 study that has completed, run by Antonios Likourezos. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01904071, a Phase 4 study, has completed, sponsored by Antonios Likourezos.

COMPLETED
Registry status
Phase 4
Development phase
64 participants
Enrollment target

Study Summary

Hip Fracture (HFx) is a painful injury that is often treated in the Emergency Department (ED) with intravenous opiates. However, this class of medications may cause deleterious side effects. An alternative analgesic approach involves regional anesthesia. The investigators attempted to determine (1) whether ultrasound guided peripheral nerve blocks (UPNBs) could be safely performed in an ED setting, (2) whether UPNBs would be more effective than standard treatment in controlling pain from HFx and (3) which of two UPNBs was superior for pain relief. A convenience sample of patients with an isolated HFx and a pain score \> 5/10 were enrolled and randomized to one of three arms: (1) Ultrasound guided 3-in-1 femoral nerve block (UFNB), (2) Ultrasound guided fascia iliaca compartment block (UFIB), or (3) IVMS. Patients indicated their pain from 0 (no pain) to 10 (extreme pain).

Interventions

  • PROCEDURE UFNB (Ultrasound guided femoral nerve block)
  • PROCEDURE UFIB (Ultrasound Guided Fascia Iliaca Compartment Block)
  • DRUG IVMS (IV Morphine)

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2008-10
Est. Completion 2010-08
Phase Phase 4

Sponsor

Antonios Likourezos

33 total trials

What the Registry Record Tells You About NCT01904071

The ClinicalTrials.gov registry entry for NCT01904071 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which UFNB (Ultrasound guided femoral nerve block) is the first listed.

NCT01904071 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01904071 about?

NCT01904071 is a clinical study titled "Ultrasound Guided Pain Control Versus Standard Treatment in Emergency Department HIP Fracture Patients". Hip Fracture (HFx) is a painful injury that is often treated in the Emergency Department (ED) with intravenous opiates. However, this class of medications may cause deleterious side effects. An alternative analgesic approach involves regional anesthesia. The investigators attempted to determine (1) ...

What is the current status of trial NCT01904071?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2008-10. Estimated completion is 2010-08.

What interventions are being tested in trial NCT01904071?

The interventions under investigation include: UFNB (Ultrasound guided femoral nerve block) (PROCEDURE), UFIB (Ultrasound Guided Fascia Iliaca Compartment Block) (PROCEDURE), IVMS (IV Morphine) (DRUG).

Who is sponsoring clinical trial NCT01904071?

This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.